Disease Background: Breast cancer is the most commonly diagnosed cancer in women, accounting for 28% of all cancers diagnosed in women this year. One of every eight women will develop breast cancer in her lifetime.
2010 Projections:
Overview of the Program: Since its inception in 1992, the Breast Cancer Research Program (BCRP) has funded research targeted toward the program's vision to eradicate breast cancer. The DoD BCRP has developed a multidisciplinary research portfolio that encompasses a wide spectrum of prevention, detection, diagnosis, and treatment research projects. The BCRP specifically avoids duplication of research funded by other federal agencies. Research awards are made using a two-tier review process composed of peer and programmatic review. An important element of the BCRP's vision is to foster partnerships between scientists and consumers, who are integral participants at both levels of review. Peer review evaluates the scientific merit of the research proposals, and programmatic review determines the relevance of proposals to the BCRP vision and goals. The Integration Panel, comprised of scientists and consumers, makes final funding recommendations and provides guidance on the BCRP's investment strategies.
The program's initial success encouraged Congress to appropriate additional funds to the BCRP in subsequent years, totaling over $2.5 billion through FY10. From FY92-FY09, a total of 42,118 proposals have been received, and 5,915 awards have been funded or recommended for funding. An additional 275 awards are anticipated for FY10. All funds for FY10 awards will be obligated by September 30, 2011.
Details on each funded award are located on the CDMRP website under Search Awards. Recent highlighted research is located on the CDMRP website under Research Highlights and in the Program Booklet.
For more information, please contact cdmrpwebmaster@cdmrp.org.
2010 Projections:
- An estimated 207,090 women in the United States will receive a diagnosis of invasive breast cancer.
- An estimated 54,010 women will be diagnosed with in situ breast cancer.
- An estimated 39,840 women will die of breast cancer.
- Although male breast cancer is rare, an estimated 1,970 men will be diagnosed with breast cancer and approximately 390 men will die of the disease.
Overview of the Program: Since its inception in 1992, the Breast Cancer Research Program (BCRP) has funded research targeted toward the program's vision to eradicate breast cancer. The DoD BCRP has developed a multidisciplinary research portfolio that encompasses a wide spectrum of prevention, detection, diagnosis, and treatment research projects. The BCRP specifically avoids duplication of research funded by other federal agencies. Research awards are made using a two-tier review process composed of peer and programmatic review. An important element of the BCRP's vision is to foster partnerships between scientists and consumers, who are integral participants at both levels of review. Peer review evaluates the scientific merit of the research proposals, and programmatic review determines the relevance of proposals to the BCRP vision and goals. The Integration Panel, comprised of scientists and consumers, makes final funding recommendations and provides guidance on the BCRP's investment strategies.
The program's initial success encouraged Congress to appropriate additional funds to the BCRP in subsequent years, totaling over $2.5 billion through FY10. From FY92-FY09, a total of 42,118 proposals have been received, and 5,915 awards have been funded or recommended for funding. An additional 275 awards are anticipated for FY10. All funds for FY10 awards will be obligated by September 30, 2011.
Details on each funded award are located on the CDMRP website under Search Awards. Recent highlighted research is located on the CDMRP website under Research Highlights and in the Program Booklet.
For more information, please contact cdmrpwebmaster@cdmrp.org.
